10/19/2005 5:12:59 PM
GLENMARK Laboratories Ltd and Tasc Pharmaceuticals Ltd have amalgamated their operations to form a combined entity that will have a presence in the entire pharmaceutical value chain.
Mr Mark Saldanha, Managing Director of the unlisted Glenmark Labs, told newspersons that the combined entity is valued at Rs 1,200 crore. Having a presence in pharmaceuticals and biologicals, the merged entity would be present both in the bulk drug and the finished dosage form segments, he said.
comments powered by